Risk of liver-related events by age and diabetes duration in patients with diabetes and nonalcoholic fatty liver disease.
Xinrong ZhangGrace Lai-Hung WongTerry Cheuk-Fung YipJohnny T K CheungYee-Kit TseVicki Wing-Ki HuiHuapeng LinJimmy Che-To LaiHenry Lik-Yuen ChanAlice Pik-Shan KongVincent Wai-Sun WongPublished in: Hepatology (Baltimore, Md.) (2022)
Age rather than duration of T2D predicts liver-related events in patients with NAFLD and T2D. It is reasonable to screen patients with NAFLD and T2D for advanced liver disease starting at 50 years of age.